Rede D'Or São Luiz S.A.'s (BVMF:RDOR3) Share Price Matching Investor Opinion
Jan 17
Have your own idea? Try our Stock Screener
Brazilian (BOVESPA) Healthcare Sector Analysis
UpdatedJan 21, 2025
DataAggregated Company Financials
Companies17
- 7D3.3%
- 3M-19.7%
- 1Y-24.8%
- YTD4.5%
Over the last 7 days, the Healthcare industry has risen 1.7%, driven by gains from Rede D'Or São Luiz of 2.5%. During this same period, the Blau Farmacêutica underperformed, falling 7.1%. In the past year, the industry is down 27%. Looking forward, earnings are forecast to grow by 26% annually.
Sector Valuation and Performance
Has the Brazilian Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 21 Jan 2025 | R$112.6b | R$146.7b | R$4.7b | 10.6x | 24.1x | 0.8x |
| Thu, 19 Dec 2024 | R$113.3b | R$146.7b | R$4.7b | 11.2x | 24.3x | 0.8x |
| Sat, 16 Nov 2024 | R$131.3b | R$147.6b | R$5.4b | 12.2x | 24.1x | 0.9x |
| Mon, 14 Oct 2024 | R$142.3b | R$144.9b | R$4.4b | 10.7x | 32.3x | 1x |
| Wed, 11 Sep 2024 | R$158.7b | R$144.9b | R$4.4b | 11.6x | 36.1x | 1.1x |
| Fri, 09 Aug 2024 | R$149.1b | R$143.4b | R$4.1b | 11.7x | 36x | 1x |
| Sun, 07 Jul 2024 | R$142.2b | R$142.9b | R$4.2b | 11.8x | 34x | 1x |
| Tue, 04 Jun 2024 | R$142.8b | R$142.9b | R$4.2b | 11.4x | 34.2x | 1x |
| Thu, 02 May 2024 | R$138.3b | R$140.1b | R$3.2b | 12.2x | 42.9x | 1x |
| Sat, 30 Mar 2024 | R$141.7b | R$139.6b | R$2.8b | 13.1x | 50.1x | 1x |
| Mon, 26 Feb 2024 | R$143.4b | R$132.9b | R$2.7b | 16.2x | 52.9x | 1.1x |
| Wed, 24 Jan 2024 | R$152.3b | R$135.0b | R$2.9b | 18.8x | 52.8x | 1.1x |
| Fri, 22 Dec 2023 | R$165.2b | R$135.0b | R$2.9b | 20.5x | 57.3x | 1.2x |
| Sun, 19 Nov 2023 | R$161.6b | R$135.0b | R$2.9b | 14.9x | 55.9x | 1.2x |
| Tue, 17 Oct 2023 | R$149.0b | R$126.1b | R$2.7b | 18.2x | 54.2x | 1.2x |
| Thu, 14 Sep 2023 | R$175.1b | R$126.1b | R$2.7b | 20.1x | 63.7x | 1.4x |
| Sat, 12 Aug 2023 | R$187.0b | R$125.0b | R$2.7b | 28.2x | 69.4x | 1.5x |
| Mon, 10 Jul 2023 | R$185.4b | R$116.7b | R$2.8b | 17.1x | 65.8x | 1.6x |
| Wed, 07 Jun 2023 | R$173.7b | R$116.7b | R$2.8b | 16.5x | 61.4x | 1.5x |
| Fri, 05 May 2023 | R$135.0b | R$106.5b | R$3.3b | 14.9x | 40.8x | 1.3x |
| Sun, 02 Apr 2023 | R$130.6b | R$106.3b | R$3.3b | 14.5x | 39.3x | 1.2x |
| Tue, 28 Feb 2023 | R$162.3b | R$98.8b | R$4.2b | 14.9x | 38.3x | 1.6x |
| Thu, 26 Jan 2023 | R$172.2b | R$98.3b | R$4.2b | 15.3x | 41.3x | 1.8x |
| Sat, 24 Dec 2022 | R$167.6b | R$98.3b | R$4.2b | 15.6x | 40.2x | 1.7x |
| Mon, 21 Nov 2022 | R$170.2b | R$98.3b | R$4.2b | 16x | 40.9x | 1.7x |
| Wed, 19 Oct 2022 | R$193.9b | R$90.4b | R$4.6b | 16.7x | 42.2x | 2.1x |
| Fri, 16 Sep 2022 | R$196.3b | R$90.4b | R$4.6b | 15.1x | 42.7x | 2.2x |
| Sun, 14 Aug 2022 | R$205.6b | R$88.9b | R$4.6b | 14.8x | 44.3x | 2.3x |
| Tue, 12 Jul 2022 | R$173.7b | R$84.2b | R$5.2b | 13.6x | 33.2x | 2.1x |
| Thu, 09 Jun 2022 | R$180.9b | R$84.2b | R$5.2b | 13.2x | 34.6x | 2.1x |
| Sat, 07 May 2022 | R$199.3b | R$78.7b | R$5.7b | 12.5x | 34.8x | 2.5x |
| Mon, 04 Apr 2022 | R$273.2b | R$77.0b | R$5.6b | 15.3x | 48.9x | 3.6x |
| Wed, 02 Mar 2022 | R$308.2b | R$87.6b | R$5.7b | 13.6x | 53.7x | 3.5x |
| Fri, 28 Jan 2022 | R$260.7b | R$87.0b | R$5.7b | 14.8x | 45.6x | 3x |
Price to Earnings Ratio
45.6x
Current Industry PE
- Investors are pessimistic on the Brazilian Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 24.1x which is lower than its 3-year average PE of 44.1x.
- The 3-year average PS ratio of 1.6x is higher than the industry's current PS ratio of 0.77x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have declined 6.6% per year over the last three years.
- Meanwhile revenues for these companies have grown 19% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the Brazilian Healthcare sector?
| BR Market | 2.72% | |
| Healthcare | 3.34% | |
| Healthcare Services | 3.69% | |
| Pharma | 2.35% | |
| Healthtech | 0% | 0 |
| Life Sciences | 0% | 0 |
| Biotech | -2.41% | |
| Medical Equipment | -8.29% | |
Industry PE
- Investors are most optimistic about the Healthcare Services industry even though it's trading below its 3-year average PE ratio of 91.5x.
- Analysts are expecting annual earnings growth of 28.2%, which is lower than the prior year's growth of 64.3% per year.
- Investors are most pessimistic about the Pharma industry, which is trading below its 3-year average of 13.6x.
Forecasted Growth
- Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 28% over the next 5 years.
- However this is lower than its past earnings growth rate of 64% per year.
- In contrast, the Pharma industry is expected to see its earnings grow by 14% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| RDOR3 Rede D'Or São Luiz | R$27.00 | 3.6% +R$2.1b | 2.0% | PE16.7x | |
| HAPV3 Hapvida Participações e Investimentos | R$2.27 | 5.1% +R$824.4m | -40.1% | PS0.6x | |
| HYPE3 Hypera | R$18.38 | 2.2% +R$253.1m | -43.3% | PE7.4x | |
| AALR3 Alliança Saúde e Participações | R$11.21 | 15.7% +R$179.7m | 34.3% | PS1.1x | |
| FLRY3 Fleury | R$11.77 | 1.9% +R$119.7m | -27.7% | PE10.4x |
